Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 616-632 , November 2009

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review

  • Renée L. Mulder

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Center, F8 Noord, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5666370; fax: +31 20 6912231.
  • ,
  • Leontien C.M. Kremer

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Center, F8 Noord, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
  • ,
  • Hanneke M. van Santen

      Affiliations

    • Department of Paediatric Endocrinology, Emma Children’s Hospital/Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
  • ,
  • Jan Lucas Ket

      Affiliations

    • Department of Paediatrics, Waterlandziekenhuis, P.O. Box 250, 1440 AG Purmerend, The Netherlands
  • ,
  • A.S. Paul van Trotsenburg

      Affiliations

    • Department of Paediatric Endocrinology, Emma Children’s Hospital/Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
  • ,
  • Caro C.E. Koning

      Affiliations

    • Department of Radiation Oncology, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
  • ,
  • Antoinette Y.N. Schouten-van Meeteren

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Center, F8 Noord, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
  • ,
  • Huib N. Caron

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Center, F8 Noord, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
  • ,
  • Sebastian J.C.M.M. Neggers

      Affiliations

    • Department of Paediatric Oncology/Haematology, Erasmus University Medical Center/Sophia Children’s Hospital & Department of Medicine, Section Endocrinology, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Elvira C. van Dalen

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Center, F8 Noord, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands

Received 27 February 2009 ,Revised 11 June 2009 ,Accepted 15 June 2009.

References 

  1. Curry HL, Parkes SE, Powell JE, et al. Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer. 2006;42:501–505508
  2. Heymans HS, Caron HN. Childhood cancers in the Netherlands (1989–1997). Ned Tijdschr Geneeskd. 2001;145:1442–1444
  3. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297:2705–2715
  4. Shalet SM, Beardwell CG, Pearson D, et al. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf). 1976;5:287–290
  5. Darzy KH, Shalet SM. Radiation-induced growth hormone deficiency. Horm Res. 2003;59(Suppl. 1):1–11
  6. Schmiegelow M. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours. Dan Med Bull. 2006;53:326–341
  7. Thomsett MJ, Conte FA, Kaplan SL, et al. Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr. 1980;97:728–735
  8. Stahnke N, Grubel G, Lagenstein I, et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr. 1984;142:179–185
  9. Gleeson HK, Shalet SM. Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr. 2001;13:346–351
  10. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-81.
  11. Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer. 2004;11:589–602
  12. Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet. 2002;359:341–345
  13. Laupacis A, Wells G, Richardson WS, et al. Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA. 1994;272:234–237
  14. Gardner MJ, Altman DG. Statistics with confidence, 1st ed. London: BMJ Publishing Group; 1989;
  15. Gandrud LM, Wilson DM. Is growth hormone stimulation testing in children still appropriate?. Growth Horm IGF Res. 2004;14:185–194
  16. Shalet SM, Beardwell CG, Morris-Jones PH, et al. Pituitary function after treatment of intracranial tumours in children. Lancet. 1975;2:104–107
  17. Shalet SM, Beardwell CG, MacFarlane IA, et al. Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood. Acta Endocrinol (Copenh). 1977;84:673–680
  18. Shalet SM, Price DA, Beardwell CG, et al. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr. 1979;94:719–722
  19. Hirsch JF, Renier D, Czernichow P, et al. Medulloblastoma in childhood. Survival and functional results. Acta Neurochir (Wien). 1979;48:1–15
  20. Pomarede R, Czernichow P, Zucker JM, et al. Incidence of anterior pituitary deficiency after radiotherapy at an early age: study in retinoblastoma. Acta Paediatr Scand. 1984;73:115–119
  21. Voorhess ML, Brecher ML, Glicksman AS, et al. Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study. Cancer. 1986;57:1287–1291
  22. Brauner R, Prevot C, Roy MP, et al. Growth, growth hormone secretion and somatomedin C after cranial irradiation for acute lymphoblastic leukemia. Acta Endocrinol Suppl (Copenh). 1986;279:178–182
  23. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr. 1986;108:332
  24. Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood. 1986;68:1129–1135
  25. Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet. 1987;1:190–193
  26. Logghe KA, Bourguignon JP, Craen M, et al. Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia. Horm Res. 1988;30:62–67
  27. Borgström B, Bolme P. Growth and growth hormone in children after bone marrow transplantation. Horm Res. 1988;30:98–100
  28. Cicognani A, Cacciari E, Vecchi V, et al. Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth hormone release in children with prolonged survival after acute lymphocytic leukemia. Am J Dis Child. 1988;142:1199–1202
  29. Brauner R, Rappaport R, Prevot C, et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab. 1989;68:346–351
  30. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr. 1991;118:226–228
  31. Ogilvy-Stuart AL, Clark DJ, Wallace WH, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child. 1992;67:1107–1110
  32. Oberfield SE, Sklar C, Allen J, et al. Thyroid and gonadal function and growth of long-term survivors of medulloblastoma/PNET. In: Green DM, D’Angio GJ, editors. Late effects of treatment for childhood cancer. New York: Wiley-Liss Inc.; 1992, p. 55-62.
  33. Caruso-Nicoletti M, Mancuso M, Spadaro G, et al. Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia. Eur J Pediatr. 1993;152:730–733
  34. Thomas BC, Stanhope R, Plowman PN, et al. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol (Copenh). 1993;128:508–512
  35. Brauner R, Fontoura M, Zucker JM, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child. 1993;68:458–463
  36. Talvensaari KK, Lanning M, Paakko E, et al. Pituitary size assessed with magnetic resonance imaging as a measure of growth hormone secretion in long term survivors of childhood cancer. J Clin Endocrinol Metab. 1994;79:1122–1127
  37. Jereb B, Korenjak R, Krzisnik C, et al. Late sequelae in children treated for brain tumors and leukemia. Acta Oncol. 1994;33:159–164
  38. Holm K, Nysom K, Rasmussen MH, et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant. 1996;18:163–170
  39. Brauner R, Adan L, Souberbielle JC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr. 1997;130:785–792
  40. Brennan BM, Rahim A, Mackie EM, et al. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf). 1998;48:777–783
  41. Melin AE, Adan L, Leverger G, et al. Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. Eur J Pediatr. 1998;157:703–707
  42. Schmiegelow M, Lassen S, Poulsen HS, et al. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin Endocrinol (Oxf). 2000;53:191–197
  43. Heikens J, Ubbink MC, van der Pal HP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer. 2000;88:2116–2121
  44. Merchant TE, Goloubeva O, Pritchard DL, et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys. 2002;52:1264–1270
  45. Xu W, Janss A, Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab. 2003;88:4677–4681
  46. Link K, Moëll C, Garwicz S, et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 2004;89:5003–5012
  47. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303–1312
  48. Olshan JS, Gubernick J, Packer RJ, et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer. 1992;70:2013–2017
  49. Gleeson HK, Gattamaneni HR, Smethurst L, et al. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab. 2004;89:662–666
  50. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000;85:3990–3.
  51. Haddy TB, Mosher RB, Nunez SB, et al. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatr Blood Cancer. 2006;46:258–261
  52. Bidlingmaier M, Strasburger CJ. Growth hormone assays: current methodologies and their limitations. Pituitary. 2007;10:115–119
  53. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab. 1995;80:1532–1540
  54. Moher D, Pham B, Lawson ML, et al. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess. 2003;7:1–90
  55. Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008;26:1112–1118

PII: S0305-7372(09)00091-7

doi: 10.1016/j.ctrv.2009.06.004

Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 616-632 , November 2009